Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
37 Cards in this Set
- Front
- Back
|
Symptoms: intermittent
|
</=2 days/week
|
|
|
Symptoms: mild persistent
|
>2 days/week
|
|
|
Symptoms: moderate persistent
|
daily
|
|
|
Symptoms: severe persistent
|
throughout the day
|
|
|
nighttime awakenings: intermittent
|
</=2x/month
|
|
|
nighttime awakenings: mild persistent
|
3-4x/month
|
|
|
nighttime awakenings: mod persistent
|
>1x/week
|
|
|
nighttime awakenings: severe persistent
|
often 7x/week (nightly)
|
|
|
SABA use: intermittent
|
</=2days /week
|
|
|
SABA use: mild persistent
|
>2days/week
|
|
|
SABA use: moderate persistent
|
daily
|
|
|
SABA use: severe persistent
|
several times/day
|
|
|
interference with ADL: intermittent
|
none
|
|
|
interference with ADL: mild persistent
|
minor limitation
|
|
|
interference with ADL: moderate persistent
|
some limitation
|
|
|
interference with ADL: severe persistent
|
extremely limited
|
|
|
FEV1: intermittent
|
>80% predicted; normal between exacerbations
|
|
|
FEV1: mild persistent
|
>80% predicted
|
|
|
FEV1: moderate persistent
|
>60% predicted
|
|
|
FEV1: severe persistent
|
<60% predicted
|
|
|
FEV1/FVC: intermittent
|
normal
|
|
|
FEV1/FVC: mild persistent
|
normal
|
|
|
FEV1/FVC: moderate persistent
|
reduced 5%
|
|
|
FEV1/FVC: severe persistent
|
reduced >5%
|
|
|
recommended step for initiating treatment: intermittent
|
step 1
|
|
|
recommended step for initiating treatment: mild persistent
|
step 2
|
|
|
recommended step for initiating treatment: moderate persistent
|
step 3; consider short course of oral systemic steroids
|
|
|
recommended step for initiating treatment: severe persistent
|
step 4 or 5; consider short course of oral systemic steroids
|
|
|
Step 1
|
SABA PRN
|
|
|
Step 2
|
low-dose ICS
|
|
|
Step 3
|
Low-dose ICS + LABA or medium dose ICS
|
|
|
Step 4
|
medium-dose ICS + LABA
|
|
|
Step 5
|
high dose ICS + LABA AND consider omalizumab for patients who have allergies
|
|
|
step 6
|
high dose ICS + LABA + oral corticosteroids and consider omalizumab for patients who have allergies
|
|
|
when to step down
|
asthma well controlled x at least 3 months
|
|
|
what to do before stepping up?
|
check adherence, environmental control, comorbid conditions
|
|
|
when to consider pulmonary cosultation
|
step 3; definitely consult with asthma specialist if step 4 care or higher is required
|
